Cocrystal Pharma
COCP
24 hedge funds and large institutions have $1.06M invested in Cocrystal Pharma in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.
0.37% more ownership
Funds ownership: 7% → 7.36% (+0.37%)
0% more funds holding
Funds holding: 24 → 24 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
26% less capital invested
Capital invested by funds: $1.44M → $1.06M (-$373K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
+$111K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$40.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$19.9K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$18.7K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.89K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$109K |
| 2 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$20.2K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$782 |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$467 |
| 5 |
Renaissance Technologies
New York
|
-$373 |
COCP Hedge Fund Activity: Q1 2025 in Review
24 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q1 2025, worth a combined $1.06M — down 26% from $1.44M a quarter earlier.
Fund positioning in COCP was balanced in Q1 2025: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 5 trimmed.
The largest buyer was Neuberger Berman Group, opening a new position worth an estimated $111K. The largest seller was Morgan Stanley, cutting an estimated $109K.
- 24 institutional investors held Cocrystal Pharma (COCP) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $1.06M of Cocrystal Pharma stock for Q1 2025, down 26% quarter-over-quarter.
- 2 funds opened new Cocrystal Pharma positions in Q1 2025 and 2 closed out, a net change of 0 holders.
- The largest Cocrystal Pharma buyer in Q1 2025 was Neuberger Berman Group, an estimated $111K added.
- The largest Cocrystal Pharma seller in Q1 2025 was Morgan Stanley, an estimated $109K sold.
Based on aggregated 13F filings for Q1 2025.